The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes after initial refusal of curative treatment in patients with Hodgkin’s lymphoma in British Columbia.
 
Manik Chahal
No Relationships to Disclose
 
Aixiang Jiang
No Relationships to Disclose
 
Anna Hayden
No Relationships to Disclose
 
Kerry J. Savage
Honoraria - Abbvie; AstraZeneca; Bristol-Myers Squibb; Gilead Sciences; Kyowa; Merck; Novartis; Novartis; Novartis Canada Pharmaceuticals Inc; Seagen
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Gilead Sciences; Merck; Seagen; Servier
Research Funding - Bristol-Myers Squibb (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Seagen
(OPTIONAL) Uncompensated Relationships - Beigene
 
Diego Villa
Honoraria - Abbvie; Acerta Pharma/AstraZeneca; Celgene; Gilead Sciences; Janssen; Lundbeck Canada; Merck; NanoString Technologies; Roche Canada; Seagen
Consulting or Advisory Role - Abbvie; Acerta Pharma/AstraZeneca; Celgene; Gilead Sciences; Janssen; Lundbeck Canada; NanoString Technologies; Roche Canada; Seagen
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Acerta Pharma; Janssen; Lundbeck Canada; Roche Canada
 
David W. Scott
Consulting or Advisory Role - Abbvie; AstraZeneca; Celgene; Janssen
Research Funding - Janssen; NanoString Technologies; Roche/Genentech
Patents, Royalties, Other Intellectual Property - As a member of the LLMPP I am potentially a named inventor on a pending patent on the use of gene expression profiling to assign cell-of-origin in diffuse large B-cell lymphoma.; I am a named inventor on a pending patent on the use of gene expression profiling to determine the proliferation signature in mantle cell lymphoma.; Named inventor on a pending patent describing gene expression profiling in prognostication in classical Hodgkin lymphoma.; Named inventor on a pending patent describing using gene expression profiling to identify molecular subtypes of GCB-DLBCL.
 
Alina S. Gerrie
Honoraria - Abbvie; Abbvie; Janssen
Consulting or Advisory Role - Abbvie; AstraZeneca; Janssen; Sandoz
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Janssen (Inst); Roche Canada (Inst)
Travel, Accommodations, Expenses - Janssen
 
Andrea Lo
No Relationships to Disclose
 
Matthew Chan
No Relationships to Disclose
 
Tom Pickles
Honoraria - Abbvie; TerSera
Research Funding - Astellas Oncology
 
Joseph M. Connors
Patents, Royalties, Other Intellectual Property - Evaluation of mantle cell lymphoma and methods related thereof (Inst); Methods for selecting and treating lymphoma types (Inst)
 
Laurie Helen Sehn
Honoraria - Abbvie; Acerta Pharma; Amgen; Apobiologix; AstraZeneca; Celgene; Debiopharm Group; Genmab; Gilead Sciences; Incyte; Janssen-Ortho; Karyopharm Therapeutics; Kite, a Gilead company; Lundbeck; Merck; morphosys; Roche/Genentech; Sandoz-Novartis; Seagen; Takeda; Teva; TG Therapeutics; Verastem
Consulting or Advisory Role - Abbvie; Acerta Pharma; Amgen; Amgen; apobiologix; AstraZeneca; Celgene; Debiopharm Group; Genmab; Gilead Sciences; Incyte; Janssen; Karyopharm Therapeutics; Kite, a Gilead company; Lundbeck; Merck; MorphoSys; Roche/Genentech; Sandoz-Novartis; Seagen; Takeda; Teva; TG therapeutics; TG Therapeutics; Verastem
Research Funding - Roche/Genentech (Inst); Teva (Inst)
 
Ciara L Freeman
Honoraria - Abbvie; Amgen; BMSi; Celgene; Janssen; Sanofi; Seagen
Research Funding - Roche; Teva